工程化 NK 细胞抗肿瘤及其潜在的其他应用
Engineered NK Cells Against Cancer and Their Potential Applications Beyond.
CAR-T细胞疗法在临床试验中显示出令人瞩目的客观缓解率,在某些情况下可高达80%。
46.9分
★★★☆☆
ALL SOURCES
Engineered NK Cells Against Cancer and Their Potential Applications Beyond.
CAR-T细胞疗法在临床试验中显示出令人瞩目的客观缓解率,在某些情况下可高达80%。
CXCR4 and anti-BCMA CAR co-modified natural killer cells suppress multiple myeloma progression in a xenograft mouse model.
本研究提供了实验证据,表明NK细胞上CXCR4与抗BCMA CAR的共表达可能是控制MM进展的一种有效途径。
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。